243 related articles for article (PubMed ID: 29478981)
1. Clinical forms of actinic keratosis and levels of dysplasia of the epidermis.
Oshyvalova OO; Kaliuzhna LD; Kropelnytskyi VO
Wiad Lek; 2017; 70(6 pt 1):1072-1078. PubMed ID: 29478981
[TBL] [Abstract][Full Text] [Related]
2. Contribution to characterization of skin field cancerization activity: morphometric, chromatin texture, proliferation, and apoptosis aspects.
Miola AC; Castilho MA; Schmitt JV; Marques MEA; Miot HA
An Bras Dermatol; 2019; 94(6):698-703. PubMed ID: 31789247
[TBL] [Abstract][Full Text] [Related]
3. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
4. Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin.
Fernández-Figueras MT; Carrato C; Sáenz X; Puig L; Musulen E; Ferrándiz C; Ariza A
J Eur Acad Dermatol Venereol; 2015 May; 29(5):991-7. PubMed ID: 25428612
[TBL] [Abstract][Full Text] [Related]
5. The many clinico-pathologic faces of actinic keratosis: an atlas.
Massone C; Cerroni L
Curr Probl Dermatol; 2015; 46():64-9. PubMed ID: 25561208
[TBL] [Abstract][Full Text] [Related]
6. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
Feldman SR; Fleischer AB
Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
[TBL] [Abstract][Full Text] [Related]
7. Sebaceous carcinoma in association with actinic keratosis: A report of two cases with an immunohistochemical study.
Misago N; Kuwashiro M; Tsuruta N; Narisawa Y
J Dermatol; 2015 Jun; 42(6):616-20. PubMed ID: 25808307
[TBL] [Abstract][Full Text] [Related]
8. Modern view on epidermal dysplasia carcinogenesis.
Oshyvalova O; Rossokha Z
Exp Oncol; 2019 Sep; 41(3):216-223. PubMed ID: 31569934
[TBL] [Abstract][Full Text] [Related]
9. A Novel Actinic Keratosis Field Assessment Scale for Grading Actinic Keratosis Disease Severity.
Dréno B; Cerio R; Dirschka T; Nart IF; Lear JT; Peris K; de Casas AR; Kaleci S; Pellacani G
Acta Derm Venereol; 2017 Oct; 97(9):1108-1113. PubMed ID: 28536731
[TBL] [Abstract][Full Text] [Related]
10. Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin.
Athanassiadou AM; Lazaris AC; Patsouris E; Tsipis A; Chelidonis G; Aroni K
Am J Dermatopathol; 2013 Jun; 35(4):425-31. PubMed ID: 23095338
[TBL] [Abstract][Full Text] [Related]
11. An assessment of the malignant potential of actinic keratoses and Bowen's disease: p53 and PCNA expression pattern correlate with the number of desmosomes.
Ramzi ST; Maruno M; Khaskhely NM; Khan MA; Takamiyagi A; Uezato H; Nonaka S
J Dermatol; 2002 Sep; 29(9):562-72. PubMed ID: 12392064
[TBL] [Abstract][Full Text] [Related]
12. Actinic keratoses show variable histological basal growth patterns - a proposed classification adjustment.
Schmitz L; Gambichler T; Gupta G; Stücker M; Stockfleth E; Szeimies RM; Dirschka T
J Eur Acad Dermatol Venereol; 2018 May; 32(5):745-751. PubMed ID: 28796914
[TBL] [Abstract][Full Text] [Related]
13. Spreading pigmented actinic keratosis: a review.
Uhlenhake EE; Sangueza OP; Lee AD; Jorizzo JL
J Am Acad Dermatol; 2010 Sep; 63(3):499-506. PubMed ID: 20334953
[TBL] [Abstract][Full Text] [Related]
14. Histological intralesional heterogeneity of actinic keratoses relates to field cancerization.
Schmitz L; Stücker M; Gambichler T; Stockfleth E; Dirschka T
J Dtsch Dermatol Ges; 2018 Oct; 16(10):1211-1217. PubMed ID: 30248236
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficiency of dynamic observation of patients with epidermal dysplasia of the skin.
Ziukov OL; Oshyvalova ОO
Wiad Lek; 2018; 71(3 pt 2):635-639. PubMed ID: 29783238
[TBL] [Abstract][Full Text] [Related]
16. High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma.
Boone MA; Marneffe A; Suppa M; Miyamoto M; Alarcon I; Hofmann-Wellenhof R; Malvehy J; Pellacani G; Del Marmol V
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1606-15. PubMed ID: 25656269
[TBL] [Abstract][Full Text] [Related]
17. Actinic keratosis: precancer, squamous cell carcinoma, or marker of field cancerization?
Deltondo JA; Helm KF
G Ital Dermatol Venereol; 2009 Aug; 144(4):441-4. PubMed ID: 19755947
[TBL] [Abstract][Full Text] [Related]
18. Claudin-1 expression decreases with increasing pathological grade in actinic keratosis and may be a marker of high-risk actinic keratosis.
Lee JS; Park HS; Yoon HS; Cho S
Clin Exp Dermatol; 2019 Jul; 44(5):483-490. PubMed ID: 30315595
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin 17 immunoexpression in actinic keratosis (bowenoid and nonbowenoid) and in Bowen disease.
Fernandez-Flores A
Ann Diagn Pathol; 2016 Feb; 20():1-6. PubMed ID: 26740287
[TBL] [Abstract][Full Text] [Related]
20. Mucin1 expression in focal epidermal dysplasia of actinic keratosis.
Arciniegas E; Carrillo LM; Rojas H; Ramírez R; Reyes O; Suárez A; Ortega F
Ann Transl Med; 2015 Oct; 3(17):245. PubMed ID: 26605291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
